Skip directly to content

TAGline Fall 2008

Addthis

TAGline Fall 2008

  • Premature Aging and HIV: New Links Provoke Mystery, but Research Lags
    A recent and growing worry in the AIDS treatment community concerns premature aging and shortened life spans in people with HIV—despite complete suppression of the virus by successful antiretroviral therapy.
     
  • TAG Sponsors “Cure Meeting” in Washington D.C.
    In November 2008, Treatment Action Group, the Foundation for AIDS Research, and the FAIR Foundation sponsored a meeting of leading scientists in Washington, D.C., to discuss the possible avenues—and impediments—to finding a way to eliminate HIV from the body—or at least cause long-term, drug-free remission.
     
  • Start Me Up: Questions Linger on Initiating and Switching HIV Treatment
    When and how to start antiretroviral therapy—and how to respond down the line when changes become necessary—remain unsettled questions.
     
  • Bacterial Breakout: New Studies of Microbial Translocation
    Immune activation has become a central culprit in the latest theories of how HIV causes disease. But despite increasing research on the question, the sources of immune activation continue to puzzle scientists.
     
  • The Hepatitis B Data Void: Making Treatment Decisions in an Evidence-Free Zone
    New drug development; treatment strategies; natural history; long-term outcomes: The lack of support for research on hepatitis B virus is putting millions of people with the virus at risk.
     
  • International Health Partnership: Just Another Initiative?
    Despite the constant uphill battle in getting its issues on the table and our concerns heard, civil society recognizes that the International Health Partnership presents opportunities.
     
  • TAG’s TB/HIV Project: International Advocacy Update
    TAG held a satellite meeting titled “TB/HIV Programs: Working Together to Achieve Universal Access to HIV and TB Prevention, Care, and Treatment.” The theme of the satellite meeting was TB and HIV program collaboration as a key strategy in achieving universal access for TB/HIV services, with a focus on sharing lessons learned and identifying key opportunities to encourage synergy between the two programs and other key stakeholders.
     
  • Fifty Years of AIDS Treatment: 1981–2031
    A speculative history of HIV treatment presented at the PATH aids2031 meeting “Discovery and Innovation for HIV/AIDS ” held in Seattle, November 18, 2008.